UNSPSC 51295102: Clodazon

This classification denotes an antidepressant agent with the molecular formula C18H20ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X82H6JOC4H, chemically known as 2h-benzimidazol-2-one, 5-chloro-1-(3-(dimethylamino)propyl)-1,3-dihydro-3-phenyl- (9ci) but generally known as clodazon, which bears US NIH Compound Identifier 20883. European Medicines Agency schedules Clodazon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06691MIG. The term CLODAZON is an International Non-Proprietary Name.

UNSPSC 51295102 Clodazon is a Commodity code that does not align with the state and local procurement activity recorded under it. The three recent opportunities tagged to this code procure naloxone and drug deactivation systems, therapeutic pharmacy initiatives and direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products—none of which are clodazon, an antibiotic pharmaceutical active ingredient. The mismatch suggests either miscoding at the source or a data-entry error. State and local procurement under this code shows little relevant recent activity.

The three recorded opportunities span a county health department (Seminole County, Florida), a state health and human services commission (Texas HHS Commission), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, administered by Minnesota Department of Administration). Seminole County issued an IFB on June 30, 2026, for naloxone and safe drug deactivation systems with a response deadline of July 26, 2023; Texas HHS posted an RFI on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs; and MMCAP released an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. Activity is concentrated in Florida and Texas, with Minnesota managing the cooperative. Because the code's nominal scope does not match the work being procured, this Commodity code is not a reliable vehicle for tracking state and local pharmaceutical or medical-supply procurement.